Free Trial

JPMorgan Chase & Co. Grows Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

JPMorgan Chase & Co. grew its holdings in Genpact Limited (NYSE:G - Free Report) by 8.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,400,636 shares of the business services provider's stock after purchasing an additional 271,295 shares during the quarter. JPMorgan Chase & Co. owned approximately 1.93% of Genpact worth $146,057,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of G. SRH Advisors LLC purchased a new stake in shares of Genpact during the fourth quarter valued at about $26,000. Manchester Capital Management LLC bought a new position in shares of Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC lifted its position in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after acquiring an additional 783 shares during the last quarter. UMB Bank n.a. boosted its stake in Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after acquiring an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp grew its holdings in Genpact by 38.8% in the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after purchasing an additional 453 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Insider Activity

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.

Wall Street Analysts Forecast Growth

G has been the subject of a number of recent analyst reports. Needham & Company LLC raised their price objective on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and raised their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Mizuho upped their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $48.44.

Read Our Latest Research Report on Genpact

Genpact Stock Performance

Genpact stock traded down $1.83 during midday trading on Friday, hitting $47.08. 2,182,743 shares of the company were exchanged, compared to its average volume of 1,347,002. The business has a fifty day simple moving average of $51.20 and a two-hundred day simple moving average of $45.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The firm has a market capitalization of $8.27 billion, a PE ratio of 16.58, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.44%. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact's dividend payout ratio is presently 23.94%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines